Livingstone Advises NexPhase on the Acquisition of Behavior Frontiers
Livingstone is pleased to announce the firm’s healthcare team has advised NexPhase Capital, LP (“NexPhase”) on the acquisition of Behavior Frontiers, a leading provider of Applied Behavior Analysis (“ABA”) treatment services for individuals with autism and other special needs. Terms of the transaction were not disclosed.
Behavior Frontiers was founded in 2004 by its CEO, Helen Mader, to bring consistent, high-quality care backed by cutting-edge research and data-driven practices to individuals with autism across all age groups, with a particular emphasis on early intervention care for children between the ages of 3 and 6. Today, the company operates 26 centers and provides home-based care across 12 states, helping thousands of patients and their families through the creation and provision of comprehensive and individualized ABA treatment programs.
“We are excited to be partnering with Helen and the incredible team she has built at Behavior Frontiers, which has brought transformative care to thousands of children and families over the past two decades,” said Andy Kieffer, Partner at NexPhase. “NexPhase has tremendous conviction in this business and its potential to serve more families in existing and new markets across the country. We look forward to leveraging our resources and significant experience working alongside leading ABA providers to help Behavior Frontiers continue delivering on its mission to provide personalized care for every child, one milestone at a time.”
NexPhase is a thematically driven and operationally focused lower middle-market private equity firm that makes investments in growth-oriented and capital-efficient companies within three distinct industry verticals: healthcare, software, and consumer. NexPhase partners with companies that have reached a growth inflection point and are seeking a value-added partner to help navigate the company’s “next phase.” The NexPhase team has extensive industry and operational experience, and its partners have invested together for over 15 years.
“We are pleased to have advised NexPhase on this important acquisition,” said Jim Moskal, Partner at Livingstone. “This transaction underscores our deep knowledge of the ABA and autism therapy sector and reflects our understanding of the current market landscape, as well as our ability to navigate today’s complex and evolving deal environment to help our clients achieve successful outcomes.”
“Livingstone continues to build strong momentum advising clients across the ABA, autism therapy, and broader behavioral health sectors, having completed nearly a dozen transactions to date, most notably, three recent, successful sales for Centers for Autism & Related Disorders (CARD),” added Mark Carl, Managing Director at Livingstone.
